. Pfizer says final study shows COVID-19 vaccine 95% effective, will seek FDA approval within days « JO LEE MAGAZINE

National Post – Pfizer Inc. said a final analysis of clinical-trial data showed its COVID-19 vaccine was 95 per cent effective, paving the way for the company to apply for the first U.S. regulatory authorization for a coronavirus shot within days.

The U.S. drugmaker and partner BioNTech SE said their vaccine protected people of all ages and ethnicities, with no significant safety problems so far in a trial that includes almost 44,000 participants.

Full story at National Post

Comments are closed.